View in EDS

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.

Saved in:
Bibliographic Details
Title: Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.
Authors: Lorusso D; Department of Biomedical Science, Humanitas University, Pieve Emanuele, Italy; Humanitas San Pio X Hospital, Milan, Italy. Electronic address: domenica.lorusso@hunimed.eu., Gladieff L; Oncopole Claudius Regaud IUCT-Oncopole, Toulouse, France; GINECO, Paris, France., O'Malley DM; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea., Garbaos G; Instituto Médico de la Fundación Estudios Clínicos, Santa Fe, Argentina., Fagotti A; Gynecologic Oncology Unit, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy., Gilbert L; Division of Gynecologic Oncology, Research Institute, McGill University Health Centre, Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Quesada S; GINECO, Paris, France; Montpellier Cancer Institute, Montpellier, France., Hopp E; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA., Lee YJ; Yonsei University College of Medicine, Seoul, South Korea., Oaknin A; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Scaranti M; Rede Américas Oncologia, Hospital 9 de Julho, São Paulo, Brazil., Kim BG; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Clamp A; The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK., Prillaman C; Virginia Oncology Associates, Norfolk, VA, USA., Diakos C; Royal North Shore Hospital, St Leonards, NSW, Australia., Bagaméri A; Department of Gynecology, Hungarian National Institute of Oncology, Budapest, Hungary., Leiser AL; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Salutari V; Department of Woman, Child, and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy., Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA., Follana P; GINECO, Paris, France; Centre Antoine Lacassagne, Nice, France., McClung E; Stanford University, Palo Alto, CA, USA., Carbone V; Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Slomovitz B; Mount Sinai Comprehensive Cancer Center, Miami Beach, FL, USA., Giudice E; Humanitas San Pio X Hospital, Milan, Italy., Cannizzaro MC; Department of Women and Children's Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Gavoille L; Gentilly Oncology Center, Interregional Institute of Oncology, Nancy, France., Devaux A; Oncology Department of Grand Hôpital de Charleroi, Charleroi, Belgium; Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium., Scollo P; Department of Medicine and Surgery, Kore University of Enna, Enna, Italy., Scandurra G; Dipartimento di Medicina, Kore University of Enna, Enna, Italy; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy., Cassani C; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy., Artioli G; Azienda ULSS2 Marca Trevigiana, Treviso, Italy., Van Gorp T; Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium., Santaballa A; Department of Medical Oncology, La Fe University Hospital, IIS La Fe, Valencia, Spain., Dreiling LK; Corcept Therapeutics, Redwood City, CA, USA., Kesner-Hays A; Corcept Therapeutics, Redwood City, CA, USA., Tudor IC; Corcept Therapeutics, Redwood City, CA, USA., Jubb AM; Corcept Therapeutics, Redwood City, CA, USA., Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy., Olawaiye AB; University of Pittsburgh School of Medicine and UPMC Magee-Women's Hospital, Gynecologic Oncology Group, Pittsburgh, PA, USA.
Source: Lancet (London, England) [Lancet] 2026 Apr 18; Vol. 407 (10538), pp. 1513-1524. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41974149
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lorusso+D%22">Lorusso D</searchLink>; Department of Biomedical Science, Humanitas University, Pieve Emanuele, Italy; Humanitas San Pio X Hospital, Milan, Italy. Electronic address: domenica.lorusso@hunimed.eu.<br /><searchLink fieldCode="AU" term="%22Gladieff+L%22">Gladieff L</searchLink>; Oncopole Claudius Regaud IUCT-Oncopole, Toulouse, France; GINECO, Paris, France.<br /><searchLink fieldCode="AU" term="%22O'Malley+DM%22">O'Malley DM</searchLink>; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Kim+JW%22">Kim JW</searchLink>; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Garbaos+G%22">Garbaos G</searchLink>; Instituto Médico de la Fundación Estudios Clínicos, Santa Fe, Argentina.<br /><searchLink fieldCode="AU" term="%22Fagotti+A%22">Fagotti A</searchLink>; Gynecologic Oncology Unit, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Gilbert+L%22">Gilbert L</searchLink>; Division of Gynecologic Oncology, Research Institute, McGill University Health Centre, Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Mileshkin+L%22">Mileshkin L</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Quesada+S%22">Quesada S</searchLink>; GINECO, Paris, France; Montpellier Cancer Institute, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Hopp+E%22">Hopp E</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Lee+YJ%22">Lee YJ</searchLink>; Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Oaknin+A%22">Oaknin A</searchLink>; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Scaranti+M%22">Scaranti M</searchLink>; Rede Américas Oncologia, Hospital 9 de Julho, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Kim+BG%22">Kim BG</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Clamp+A%22">Clamp A</searchLink>; The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Prillaman+C%22">Prillaman C</searchLink>; Virginia Oncology Associates, Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Diakos+C%22">Diakos C</searchLink>; Royal North Shore Hospital, St Leonards, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Bagaméri+A%22">Bagaméri A</searchLink>; Department of Gynecology, Hungarian National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Leiser+AL%22">Leiser AL</searchLink>; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Salutari+V%22">Salutari V</searchLink>; Department of Woman, Child, and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Monk+BJ%22">Monk BJ</searchLink>; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.<br /><searchLink fieldCode="AU" term="%22Follana+P%22">Follana P</searchLink>; GINECO, Paris, France; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22McClung+E%22">McClung E</searchLink>; Stanford University, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Carbone+V%22">Carbone V</searchLink>; Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Slomovitz+B%22">Slomovitz B</searchLink>; Mount Sinai Comprehensive Cancer Center, Miami Beach, FL, USA.<br /><searchLink fieldCode="AU" term="%22Giudice+E%22">Giudice E</searchLink>; Humanitas San Pio X Hospital, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Cannizzaro+MC%22">Cannizzaro MC</searchLink>; Department of Women and Children's Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Gavoille+L%22">Gavoille L</searchLink>; Gentilly Oncology Center, Interregional Institute of Oncology, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Devaux+A%22">Devaux A</searchLink>; Oncology Department of Grand Hôpital de Charleroi, Charleroi, Belgium; Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Scollo+P%22">Scollo P</searchLink>; Department of Medicine and Surgery, Kore University of Enna, Enna, Italy.<br /><searchLink fieldCode="AU" term="%22Scandurra+G%22">Scandurra G</searchLink>; Dipartimento di Medicina, Kore University of Enna, Enna, Italy; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy.<br /><searchLink fieldCode="AU" term="%22Cassani+C%22">Cassani C</searchLink>; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS San Matteo Foundation, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Artioli+G%22">Artioli G</searchLink>; Azienda ULSS2 Marca Trevigiana, Treviso, Italy.<br /><searchLink fieldCode="AU" term="%22Van+Gorp+T%22">Van Gorp T</searchLink>; Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Santaballa+A%22">Santaballa A</searchLink>; Department of Medical Oncology, La Fe University Hospital, IIS La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Dreiling+LK%22">Dreiling LK</searchLink>; Corcept Therapeutics, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kesner-Hays+A%22">Kesner-Hays A</searchLink>; Corcept Therapeutics, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tudor+IC%22">Tudor IC</searchLink>; Corcept Therapeutics, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jubb+AM%22">Jubb AM</searchLink>; Corcept Therapeutics, Redwood City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Colombo+N%22">Colombo N</searchLink>; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Olawaiye+AB%22">Olawaiye AB</searchLink>; University of Pittsburgh School of Medicine and UPMC Magee-Women's Hospital, Gynecologic Oncology Group, Pittsburgh, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2026 Apr 18; Vol. 407 (10538), pp. 1513-1524. <i>Date of Electronic Publication: </i>2026 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41974149
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(26)00462-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1513
    Titles:
      – TitleFull: Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lorusso D
      – PersonEntity:
          Name:
            NameFull: Gladieff L
      – PersonEntity:
          Name:
            NameFull: O'Malley DM
      – PersonEntity:
          Name:
            NameFull: Kim JW
      – PersonEntity:
          Name:
            NameFull: Garbaos G
      – PersonEntity:
          Name:
            NameFull: Fagotti A
      – PersonEntity:
          Name:
            NameFull: Gilbert L
      – PersonEntity:
          Name:
            NameFull: Mileshkin L
      – PersonEntity:
          Name:
            NameFull: Quesada S
      – PersonEntity:
          Name:
            NameFull: Hopp E
      – PersonEntity:
          Name:
            NameFull: Lee YJ
      – PersonEntity:
          Name:
            NameFull: Oaknin A
      – PersonEntity:
          Name:
            NameFull: Scaranti M
      – PersonEntity:
          Name:
            NameFull: Kim BG
      – PersonEntity:
          Name:
            NameFull: Clamp A
      – PersonEntity:
          Name:
            NameFull: Prillaman C
      – PersonEntity:
          Name:
            NameFull: Diakos C
      – PersonEntity:
          Name:
            NameFull: Bagaméri A
      – PersonEntity:
          Name:
            NameFull: Leiser AL
      – PersonEntity:
          Name:
            NameFull: Salutari V
      – PersonEntity:
          Name:
            NameFull: Monk BJ
      – PersonEntity:
          Name:
            NameFull: Follana P
      – PersonEntity:
          Name:
            NameFull: McClung E
      – PersonEntity:
          Name:
            NameFull: Carbone V
      – PersonEntity:
          Name:
            NameFull: Slomovitz B
      – PersonEntity:
          Name:
            NameFull: Giudice E
      – PersonEntity:
          Name:
            NameFull: Cannizzaro MC
      – PersonEntity:
          Name:
            NameFull: Gavoille L
      – PersonEntity:
          Name:
            NameFull: Devaux A
      – PersonEntity:
          Name:
            NameFull: Scollo P
      – PersonEntity:
          Name:
            NameFull: Scandurra G
      – PersonEntity:
          Name:
            NameFull: Cassani C
      – PersonEntity:
          Name:
            NameFull: Artioli G
      – PersonEntity:
          Name:
            NameFull: Van Gorp T
      – PersonEntity:
          Name:
            NameFull: Santaballa A
      – PersonEntity:
          Name:
            NameFull: Dreiling LK
      – PersonEntity:
          Name:
            NameFull: Kesner-Hays A
      – PersonEntity:
          Name:
            NameFull: Tudor IC
      – PersonEntity:
          Name:
            NameFull: Jubb AM
      – PersonEntity:
          Name:
            NameFull: Colombo N
      – PersonEntity:
          Name:
            NameFull: Olawaiye AB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 04
              Text: 2026 Apr 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 407
            – Type: issue
              Value: 10538
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1